Navigation Links
Vaginal Mesh Lawsuit News: C.R. Bard Motion to Exclude Certain Evidence Denied in Federal Bellwether Trial, Bernstein Liebhard LLP Reports
Date:1/7/2014

New York, New York (PRWEB) January 07, 2014

The federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, for vaginal mesh lawsuits (http://www.transvaginalmeshlawsuitclaims.com/) filed against C.R. Bard, Inc. continues to prepare for the litigation’s second bellwether trial, Bernstein Liebhard LLP reports. According to court documents issued January 3, 2014, the judge overseeing the proceeding has denied C.R. Bard’s motion in limine to exclude certain evidence relating to the company’s pelvic mesh devices. (Jones v. C. R. Bard, Inc. 2:11-cv-00114)

“We are following this bellwether case closely, as we are representing numerous women in transvaginal mesh lawsuits that have been filed in this proceeding. The finding of the jury in this case could provide clues as to how other juries might rule in similar claims pending against C.R. Bard,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is a member of the Plaintiffs' Steering Committee in the federal C.R. Bard litigation. Bernstein Liebhard LLP continues to offer free legal evaluations to women who allegedly suffered mesh erosion, chronic pain, infections, and other complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.

Transvaginal Mesh Lawsuits
Court documents indicate that more than 6,200 vaginal mesh lawsuits have been filed against C.R. Bard in the Southern District of West Virginia. All of the claims pending in the proceeding allege that the company’s Avaulta pelvic mesh products were defectively designed and manufactured. Plaintiffs further allege that C.R. Bard failed to provide adequate warnings to doctors and patients about their risks. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

The second federal bellwether trial in the C.R. Bard litigation is scheduled to begin Friday, January 10, 2014. According to court documents, the first bellwether case concluded in August, with the jury awarding $2 billion in damages to Plaintiff. (Cisson v. C.R. Bard Inc., 11-cv-00195)

According to court documents, C.R. Bard was ordered to pay $3.6 million of a $.5.5 million judgment rendered by a California Superior Court jury in July 2012, after the panel found that the company was partly liable for the complications suffered by another Avaulta mesh recipient. The surgeon who implanted the device was assessed the remaining portion of the judgment. (Scott v. Kannappan, S-1500-CV-266034-WDE, Superior Court for Kern County, California (Bakersfield))

Along with the federal multidistrict litigation for claims involving C.R. Bard, court filings indicate that five other consolidated proceedings involving vaginal mesh lawsuits have been established for claims naming other manufacturers as defendants. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for the following federal litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327.

Mr. Grand was also named Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).

Women who were allegedly injured by transvaginal mesh devices may be entitled to compensation for their injury-related damages, including medical expenses, lost wages, and pain and suffering. Learn more about filing a vaginal mesh lawsuit at Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.transvaginalmeshlawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/transvaginal-mesh-lawsuit/vaginal-mesh-complication/prweb11469013.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Federal Judge Orders Updated Accounting in Bard Avaulta Vaginal Mesh Lawsuits, Rottenstein Law Group LLP Reports
2. Transvaginal Mesh Lawsuit Update: Bernstein Liebhard LLP Answers Questions about Growing Litigation, Process of Filing a Claim on Newly-Launched Website
3. “Tips To Get Rid Of Vaginal Odor,” A New Article On Vkool.Com, Teaches People How To Eliminate Vaginal Odor Naturally - V-kool
4. Bernstein Liebhard LLP Launches New Transvaginal Mesh Lawsuit Website as Claims Continue to Mount in U.S. Litigations
5. Transvaginal Mesh Lawsuits Move Forward, as Federal Litigations Prep for 2014 Bellwether Trials, Bernstein Liebhard LLP Reports
6. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order Pertaining to Discovery in Federal Boston Scientific Litigation
7. Ethicon Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Release of New Order in Federal Ethicon Mesh Litigation Concerning Upcoming Bellwether Trial
8. Transvaginal Mesh Lawsuits Move Forward, As Bernstein Liebhard LLP Notes New Order in Federal Boston Scientific Litigation
9. Vaginal Mesh Lawsuit News: Federal Judge Overseeing American Medical Systems Litigation Sets Order of First Bellwether Trials, Bernstein Liebhard LLP Reports
10. Increase to Almost 40,000 Transvaginal Mesh Lawsuits in Federal Court Leads to Expanded Leadership Committee, Notes Rottenstein Law Group LLP
11. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Plaintiff Filing in Federal Ethicon Vaginal Mesh Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: